Does the POR rs1057868 (A503V, POR*28) variant alter steroidogenic enzyme activity and steroid hormone levels?

The POR rs1057868 (A503V, POR*28) variant is a well-characterized functional polymorphism that significantly impacts the biosynthesis of steroid hormones and the metabolism of various drugs. As the primary electron donor for microsomal cytochrome P450 (CYP) enzymes, POR is essential for maintaining proper enzymatic flux in steroidogenic pathways.

Impact on enzyme activity and steroidogenesis

• Research confirms that the POR*28 variant reduces the catalytic efficiency of several cytochrome P450 enzymes. Specifically, it decreases the activity of CYP17A1 and CYP21A2, which are critical for producing cortisol, mineralocorticoids, and sex steroids.
• In functional assays, POR*28 reduced the 21-hydroxylase activity of CYP21A2 by approximately 40%. For CYP17A1, the variant reduced electron transfer efficiency to about 60% of wild-type levels. The impact is particularly pronounced on the 17,20-lyase reaction compared to the 17α-hydroxylase reaction.

Mechanistic explanations

• The A503V substitution occurs within the FMN-binding domain of the POR protein. This structural change impairs the docking efficiency and the shuttling of electrons from NADPH through the flavin cofactors (FAD and FMN) to the CYP heme site.
• The disproportionate impact on CYP17A1’s lyase activity is due to the reaction's requirement for two sequential oxidation cycles. This makes the pathway more sensitive to suboptimal electron delivery and the availability of cofactors like cytochrome b5.

Clinical and hormonal implications

• These enzymatic shifts lead to altered steroid profiles, characterized by lower androgen levels (e.g., testosterone) and an accumulation of precursors such as 17-hydroxyprogesterone (17-OHP).
• While POR*28 acts as a significant phenotype modifier in conditions like congenital adrenal hyperplasia—potentially masking hyperandrogenism—its effects on systemic hormone levels in the general population are often subtle and can be mitigated by compensatory physiological mechanisms.

Bottom line

The POR*28 variant is a scientifically supported modifier of POR enzyme activity that impairs steroidogenesis by reducing electron transfer efficiency to CYP17A1 and CYP21A2. This leads to detectable changes in steroid hormone levels, particularly in the androgenic pathway, though clinical presentation varies significantly based on individual health context.